Showing results (2011-2020 of 3,176) with videos related to

Sort By:
Pageof 318
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|September 28, 2020
[Clinical analysis of 14 cases with childhood acute lymphoblastic leukemia complicated with tropical candidemia]L Yan, M C Zheng, X L Ju, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 28, 2015
Dysregulation of Hypothalamo-Pituitary-Adrenocortical Axis in Overweight Female Diabetic Subjects is Associated with Downregulation of Corticosteroid Receptors and 11β-HSD1 in the BrainS Li, Y Liao, L Wang, et al.
Gene Therapy|July 1, 2015
The spread of adenoviral vectors to central nervous system through pathway of cochlea in mimetic aging and young ratsX Chen, X Zhao, Y Hu, et al.
Andrologia|November 11, 2014
Strontium fructose 1, 6-diphosphate alleviate cyclophosphamide-induced oligozoospermia by improving antioxidant and inhibiting testicular apoptosis via FAS/FASL pathwayJ Li, Y Hu, Q Zhang, et al.
Herz|August 31, 2014
E-selectin gene polymorphism (A561C) and essential hypertension. Meta-analysis in the Chinese populationY Ouyang, H Wu, A Tan, et al.
Epidemiology and Infection|January 9, 2016
Multilocus sequence typing of 102 Burkholderia pseudomallei strains isolated from ChinaY Fang, P Zhu, Q Li, et al.
Cell Death & Disease|July 24, 2015
Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver diseaseW Shan, L Gao, W Zeng, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|November 28, 2024
[The clinical effect of flow-diverting stent for treatment of unruptured internal carotid artery small- and medium-sized wide-neck aneurysms]J Bao, Y Cao, X Zhang, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|November 10, 2024
[Aumolertinib combined with anlotinib inhibits proliferation of non-small cell lung cancer cells by down-regulating the PI3K/AKT pathway]Y Yang, X Liu, W Liu, et al.
ESMO Open|October 26, 2024
Tislelizumab plus chemotherapy as first-line treatment of locally advanced or metastatic nonsquamous non-small-cell lung cancer (final analysis of RATIONALE-304: a randomized phase III trial)S Lu, J Wang, Y Yu, et al.
Pageof 318